Evidence map›Paper›PMID 37110649›Full record

ArticleMolecules (Basel, Switzerland)2023

Mohammed Hasan Mukhtar, Mahmoud Zaki El-Readi, Mohamed E Elzubier, Sameer H Fatani, Bassem Refaat, Usama Shaheen, Elshiekh Babiker Adam Khidir, Hesham Hamada Taha, Safaa Yehia Eid

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Current issues in molecular biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Mohammed Hasan MukhtarDepartment of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Al-Abdeyah, Makkah 24381, Saudi Arabia.ORCID 0000-0003-0671-2458
Mahmoud Zaki El-ReadiDepartment of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Al-Abdeyah, Makkah 24381, Saudi Arabia.ORCID 0000-0001-8398-5412
Mohamed E ElzubierDepartment of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Al-Abdeyah, Makkah 24381, Saudi Arabia.ORCID 0000-0002-6335-1778
Sameer H FataniDepartment of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Al-Abdeyah, Makkah 24381, Saudi Arabia.
Bassem RefaatLaboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al-Abdeyah, Makkah 24381, Saudi Arabia.ORCID 0000-0003-4267-1016
Usama ShaheenDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Cairo 11829, Egypt.
Elshiekh Babiker Adam KhidirLaboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al-Abdeyah, Makkah 24381, Saudi Arabia.
Hesham Hamada TahaBiochemistry and Molecular Biology Department, Faculty of Pharmacy, Al-Azhar University, Assuit 71524, Egypt.
Safaa Yehia EidDepartment of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Al-Abdeyah, Makkah 24381, Saudi Arabia.
Umm al-Qura University · SAAl-Azhar University · EG

Funding

Deanship of Scientific Research (formerly Institute of Scientific Research and Revival of Islamic Heritage), Umm Al-Qura University, Makkah, KSA, for funding this project 43509093
6 · The paper itself

Abstract

Multidrug resistance (MDR) is the major complex mechanism that causes the failure of chemotherapy, especially with drugs of natural origin such as doxorubicin (DOX). Intracellular drug accumulation and detoxification are also involved in cancer resistance by reducing the susceptibility of cancer cells to death. This research aims to identify the volatile composition of

Indexed as

CymbopogonNeoplasmsOils, VolatileAcyclic MonoterpenesAnimalsDoxorubicinDrug Resistance, MultipleDrug Resistance, NeoplasmHumansAcyclic MonoterpenescitralDoxorubicinOils, VolatilecitralCymbopogon citratusdoxorubicinessential oilGC-MSlemon grassmultidrug resistance

Identifiers

PMID37110649
PMCPMC10143904
OpenAlexW4365454265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.